Medical Health Cluster

Variantes Covid

What is the new COVID-19 variant BA.2, and will it cause another wave of infections in the US?

A new omicron subvariant of the virus that causes COVID-19, BA.2, is quickly becoming the predominant source of infections amid rising cases around the world. Immunologists Prakash Nagarkatti and Mitzi Nagarkatti of the University of South Carolina explain what makes it different from previous variants, whether there will be another […]

Read More

Even Mild COVID-19 May Change the Brain

Alarge study comparing brain scans from the same individuals before and after SARS-CoV-2 infection suggests that brain changes could be a lingering outcome of even mild COVID-19. Writing in Nature, researchers at Oxford University’s Wellcome Centre for Integrative Neuroimaging reported that several months after study participants had SARS-CoV-2 infections, they had more gray […]

Read More

Federal Government Buys Thousands of Bebtelovimab Doses

The US Department of Health and Human Services (HHS) has purchased 600 000 treatment courses of bebtelovimab—a monoclonal antibody that research shows effectively treats the SARS-CoV-2 Omicron variant. Omicron is currently responsible for almost all COVID-19 cases in the US, according to an HHS statement. “We want to make sure if an […]

Read More

More COVID Deaths in Counties With Lower Internet Access

U.S. communities with limited internet access reported higher COVID-19 death rates during the first year of the pandemic, according to a recent study published in JAMA Network Open. Between 2.4 and six deaths per 100,000 people could have been prevented, the researchers estimated, depending on whether they were in rural, suburban or urban […]

Read More

FDA to Consider Future of COVID Booster Doses

The FDA today announced its vaccines advisory committee will meet April 6 to discuss the future of COVID-19 booster doses and how to tell if a specific strain of the coronavirus needs its own vaccine. The independent experts on the Vaccines and Related Biological Products Advisory Committee will be joined by representatives […]

Read More

El tercer pilar de la educación médica

La pandemia de COVID-19 ha cambiado nuestro paradigma de lo que conlleva la palabra salud y su extensión en varios aspectos, asimismo, nos ha demostrado las vulnerabilidades que el sistema de salud mexicano arrastra desde hace varios años y su poca resiliencia ante la catástrofe que se ha extendido durante los últimos dos […]

Read More

COVID-19–alopecia areata link? Review doesn’t find much evidence

A new systematic literature review suggests that there may be – at most – a weak link between COVID-19 and alopecia areata. If there is a connection, it’s likely not a strong one, said study author Rachel E. Christensen, a graduate student at Rutgers Robert Wood Johnson Medical School, in an […]

Read More

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron

In this open-label, nonrandomized clinical study, we assessed the immunogenicity and safety of a fourth dose of either BNT162b2 (Pfizer–BioNTech) or mRNA-1273 (Moderna) administered 4 months after the third dose in a series of three BNT162b2 doses (ClinicalTrials.gov numbers, NCT05231005. opens in new tab and NCT05230953. opens in new tab; the protocol is available with […]

Read More

Los cambios cognitivos y electroencefalográficos posteriores a la COVID-19 persisten hasta por 10 meses

Los pacientes que se recuperan de COVID-19 muestran anomalías cognitivas, de electroencefalografía y de resonancia magnética interrelacionadas 2 meses después del alta hospitalaria, y algunas “alteraciones” persisten hasta 10 meses después, sugiere una nueva investigación.[1] En una cohorte de pacientes ingresados en el Servicio de Urgencias con diagnóstico de COVID-19, […]

Read More

Aerosolized Hydrogen Peroxide Can Significantly Reduce C. difficile Infections

Aerosolized hydrogen peroxide (aHP) can significantly reduce Clostridioides difficile infection (CDI) and is an effective disinfection system, suggests a new study published in the American Journal of Infection Control. C. difficile is the most common cause of healthcare-associated infection and increasingly occurs outside acute care hospitals. CDI symptoms can range from mild diarrhea to life-threatening colitis and sepsis, sometimes requiring urgent colon removal. […]

Read More